GlaxoSmithKline’s quadrivalent influenza vaccine approved in UK and Germany | Influenza | Scoop.it

GlaxoSmithKline’s quadrivalent influenza vaccine has been granted marketing authorisation in Germany and the UK. The four-strain vaccine is the first  to be approved in a European country for active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the two influenza A and two influenza B virus subtypes contained within the vaccine.


Via Ed Rybicki